Clinical Trial Update: Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease [Phase 3]

View source ↗

Summary

Phase 3 trial comparing two dosing regimens of olokizumab (OKZ) to placebo and adalimumab in methotrexate-treated rheumatoid arthritis with active disease; resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)
• olokizumab (OKZ) (olokizumab)

Snippet

Sponsor: R-Pharm International, LLC | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2021-04-30